Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SMALL CELL LUNG CARCINOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00351962
What this trial is testing

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours

Who this might be right for
Lung NeoplasmsLung Cancer
AHS Cancer Control Alberta 58
Testing effectiveness (Phase 2)Study completedNCT00157209
What this trial is testing

Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell Lung
Merck KGaA, Darmstadt, Germany 171
Not applicableStudy completedNCT04676321
What this trial is testing

Key Performance Indicators for the Assessment of NSCLC Patients Pathway

Who this might be right for
Non Small Cell Lung Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 430
Not applicableStudy completedNCT07267247
What this trial is testing

Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer (MeSH Term: Carcinoma, Non-Small-Cell Lung)Drug-Related Side Effects and Adverse Reactions (MeSH Term)Egfr Tyrosine Kinase Inhibitor+1 more
Taichung Veterans General Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07472647
What this trial is testing

SYS6090 Combination Therapy in Advanced Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung Cancer
Shanghai JMT-Bio Inc. 596
Testing effectiveness (Phase 2)Study completedNCT00743938
What this trial is testing

A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Bristol-Myers Squibb 141
Large-scale testing (Phase 3)Looking for participantsNCT06899126
What this trial is testing

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Daiichi Sankyo 686
Early research (Phase 1)Active Not RecruitingNCT03807778
What this trial is testing

Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Takeda 53
Testing effectiveness (Phase 2)Looking for participantsNCT06907615
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Henlius Biotech 243
Testing effectiveness (Phase 2)Ended earlyNCT04951115
What this trial is testing

A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Weill Medical College of Cornell University 6
Early research (Phase 1)Looking for participantsNCT06266299
What this trial is testing

KK2269 in Adult Participants With Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorGastric Adenocarcinoma+3 more
Kyowa Kirin Co., Ltd. 101
Testing effectiveness (Phase 2)Study completedNCT00191763
What this trial is testing

Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell-Lung Cancer
Eli Lilly and Company 52
Not applicableStudy completedNCT00303914
What this trial is testing

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+4 more
Eastern Cooperative Oncology Group 2,310
Post-approval studies (Phase 4)Study completedNCT00115206
What this trial is testing

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Amgen
Testing effectiveness (Phase 2)Ended earlyNCT02325349
What this trial is testing

PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents

Who this might be right for
Advanced Head and Neck CarcinomaAdvanced Non-small Cell Lung Carcinoma
Assistance Publique - Hôpitaux de Paris 1
Early research (Phase 1)Study completedNCT00372515
What this trial is testing

High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations

Who this might be right for
Non-Small Cell Lung Cancer
David M. Jackman, MD 7
Testing effectiveness (Phase 2)Study completedNCT00084409
What this trial is testing

Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease

Who this might be right for
Lung CancerPrecancerous Condition
University of Colorado, Denver 152
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07108816
What this trial is testing

A Single-center, Phase II Clinical Trial Evaluating the Efficacy of Sacituzumab Tirumotecan in Combination With Tagitanlimab as Neoadjuvant Therapy for PD-L1-positive, Resectable Stage II to IIIB Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Resectable Stage II-IIIB NSCLC
Henan Cancer Hospital 52
Early research (Phase 1)Not Yet RecruitingNCT07358884
What this trial is testing

First in Human Study of QLS5316 in Solid Tumors

Who this might be right for
Solid TumorsColorectal CancerGastric Cancer or Gastroesophageal Junction Adenocarcinoma+2 more
Qilu Pharmaceutical Co., Ltd. 300
Next Page